Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $25,915 | 1,535 | 97.6% |
| Education | $620.69 | 18 | 2.3% |
| Gift | $13.02 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $4,692 | 208 | $0 (2024) |
| Novo Nordisk Inc | $2,137 | 157 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,975 | 124 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,684 | 67 | $0 (2024) |
| Lilly USA, LLC | $1,645 | 116 | $0 (2024) |
| Amgen Inc. | $1,557 | 90 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,407 | 111 | $0 (2023) |
| PFIZER INC. | $815.69 | 62 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $774.95 | 29 | $0 (2024) |
| GENZYME CORPORATION | $609.20 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,780 | 214 | AstraZeneca Pharmaceuticals LP ($1,113) |
| 2023 | $4,259 | 224 | AstraZeneca Pharmaceuticals LP ($1,138) |
| 2022 | $3,865 | 225 | AstraZeneca Pharmaceuticals LP ($867.76) |
| 2021 | $2,938 | 190 | AstraZeneca Pharmaceuticals LP ($420.44) |
| 2020 | $2,276 | 149 | AstraZeneca Pharmaceuticals LP ($386.69) |
| 2019 | $2,740 | 170 | AstraZeneca Pharmaceuticals LP ($370.08) |
| 2018 | $2,284 | 191 | Merck Sharp & Dohme Corporation ($385.39) |
| 2017 | $3,408 | 191 | Lilly USA, LLC ($514.64) |
All Payment Transactions
1,554 individual payment records from CMS Open Payments — Page 1 of 63
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Respiratory | ||||||
| 12/13/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $15.80 | General |
| Category: Narcoplepsy | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $117.32 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Immunology | ||||||
| 12/06/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Insomnia | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $122.56 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/26/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/25/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Immunology | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Immunology | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 61 | 9,526 | 20,923 | $2.9M | $1.3M |
| 2022 | 53 | 7,816 | 16,042 | $2.4M | $1.0M |
| 2021 | 43 | 6,144 | 13,304 | $2.1M | $932,757 |
| 2020 | 46 | 5,747 | 11,559 | $1.6M | $790,513 |
All Medicare Procedures & Services
203 procedure records from CMS Medicare Utilization — Page 2 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 82 | 82 | $25,300 | $10,122 | 40.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 118 | 127 | $21,590 | $10,064 | 46.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 461 | 461 | $16,135 | $9,672 | 59.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 229 | 305 | $19,195 | $8,966 | 46.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 243 | 255 | $10,370 | $8,662 | 83.5% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 152 | 156 | $26,580 | $7,536 | 28.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 152 | 156 | $13,620 | $6,090 | 44.7% |
| 87634 | Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique | Office | 2023 | 73 | 83 | $6,640 | $5,710 | 86.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 225 | 225 | $7,875 | $4,721 | 59.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 22 | 22 | $6,600 | $3,821 | 57.9% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 118 | 120 | $7,200 | $3,521 | 48.9% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 18 | 35 | $10,450 | $2,930 | 28.0% |
| 99407 | Smoking and tobacco use intensive counseling, more than 10 minutes | Office | 2023 | 82 | 93 | $7,350 | $2,801 | 38.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 126 | 210 | $6,680 | $2,467 | 36.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 70 | 71 | $2,900 | $2,412 | 83.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 18 | 18 | $3,100 | $2,354 | 75.9% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 128 | 128 | $12,800 | $2,301 | 18.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 165 | 188 | $12,805 | $2,128 | 16.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 46 | 50 | $4,500 | $2,090 | 46.4% |
| 94200 | Test to measure largest amount of air breathed in an out | Office | 2023 | 152 | 156 | $8,040 | $2,024 | 25.2% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 175 | 366 | $5,490 | $1,591 | 29.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $3,760 | $1,184 | 31.5% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 15 | 15 | $2,625 | $1,154 | 43.9% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2023 | 12 | 13 | $1,430 | $928.31 | 64.9% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 23 | 24 | $1,440 | $825.36 | 57.3% |
About Dr. Jehad Saliba, MD
Dr. Jehad Saliba, MD is a Internal Medicine healthcare provider based in Kearny, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164480372.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jehad Saliba, MD has received a total of $26,548 in payments from pharmaceutical and medical device companies, with $4,780 received in 2024. These payments were reported across 1,554 transactions from 81 companies. The most common payment nature is "Food and Beverage" ($25,915).
As a Medicare-enrolled provider, Saliba has provided services to 29,233 Medicare beneficiaries, totaling 61,828 services with total Medicare billing of $4.1M. Data is available for 4 years (2020–2023), covering 203 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease
- Location Kearny, NJ
- Active Since 05/04/2006
- Last Updated 09/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1164480372
Products in Payments
- FASENRA (Biological) $1,355
- JARDIANCE (Drug) $1,295
- FARXIGA (Drug) $1,079
- Ozempic (Drug) $988.16
- DUPIXENT (Biological) $979.90
- TRULICITY (Drug) $725.16
- JANUVIA (Drug) $723.78
- XARELTO (Drug) $635.28
- ACTHAR (Biological) $599.34
- TRELEGY ELLIPTA (Drug) $548.74
- Rybelsus (Drug) $512.93
- XIFAXAN (Drug) $509.18
- AREXVY (Drug) $491.47
- ELIQUIS (Drug) $486.49
- NUCALA (Biological) $466.96
- PURIFIED CORTROPHIN GEL (Drug) $437.48
- QUVIVIQ (Drug) $385.65
- MOUNJARO (Drug) $381.96
- Repatha (Biological) $377.75
- AIRSUPRA (Drug) $377.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kearny
Gary Cardiello, Md, MD
Internal Medicine — Payments: $12,383
Dr. Thomas Francis, D.o, D.O
Internal Medicine — Payments: $9,319
Dr. Richard Romano, Do, Dc, DO, DC
Internal Medicine — Payments: $619.58
Prakash Doshi, M.d, M.D
Internal Medicine — Payments: $601.50
Dr. Mudassar Sharif, M.d, M.D
Internal Medicine
Salvatore Rifici, Md, MD
Internal Medicine